ME01002B - Vakcina i imunogenične kompozicije za virus plavog jezika, postupci za njihovu upotrebu i postupci za njihovu izradu - Google Patents

Vakcina i imunogenične kompozicije za virus plavog jezika, postupci za njihovu upotrebu i postupci za njihovu izradu

Info

Publication number
ME01002B
ME01002B MEP-2010-83A MEP8310A ME01002B ME 01002 B ME01002 B ME 01002B ME P8310 A MEP8310 A ME P8310A ME 01002 B ME01002 B ME 01002B
Authority
ME
Montenegro
Prior art keywords
methods
bluetongue virus
immunogenic compositions
virus vaccine
producing same
Prior art date
Application number
MEP-2010-83A
Other languages
English (en)
Inventor
Duran Joan Plana
Original Assignee
Zoetis Belgium S A
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=39295947&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ME01002(B) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Zoetis Belgium S A filed Critical Zoetis Belgium S A
Publication of ME01002B publication Critical patent/ME01002B/me

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/15—Reoviridae, e.g. calf diarrhea virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525—Virus
    • A61K2039/5252—Virus inactivated (killed)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
    • A61K2039/552—Veterinary vaccine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55505—Inorganic adjuvants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/55577—Saponins; Quil A; QS21; ISCOMS
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2720/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsRNA viruses
    • C12N2720/00011—Details
    • C12N2720/12011—Reoviridae
    • C12N2720/12111—Orbivirus, e.g. bluetongue virus
    • C12N2720/12134—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2720/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsRNA viruses
    • C12N2720/00011—Details
    • C12N2720/12011—Reoviridae
    • C12N2720/12111—Orbivirus, e.g. bluetongue virus
    • C12N2720/12161—Methods of inactivation or attenuation
    • C12N2720/12163—Methods of inactivation or attenuation by chemical treatment

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Virology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Organic Chemistry (AREA)
  • Immunology (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicinal Preparation (AREA)

Abstract

Obezbeđene su imunogenične kompozicije i kompozicije vakcine ipostupci za njihovu izradu i upotrebu, pri čemu su kompozicije efektivne uzaštiti od maksimalnog umanjivanja ozbiljnosti, prevenciji i/ili odlaganjuinfekcije preživara sa virusom plavog jezika. Primena najmanje jedne dozekompozicije dvostruko inaktiviranog virusa plavog jezika sa adjuvantom naživotinji, kako je ovde otkriveno, je efikasna u obezbeđivanju imunitetaživotinje i zaštiti od infekcije sa virusom plavog jezika, na taj načinredukujući ozbiljnost i/ili prevenciju oboljenja izazvanih jednim ili višesojeva ili serotipova virusa plavog jezika.
MEP-2010-83A 2007-11-21 2008-11-21 Vakcina i imunogenične kompozicije za virus plavog jezika, postupci za njihovu upotrebu i postupci za njihovu izradu ME01002B (me)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP07380323A EP2062594A1 (en) 2007-11-21 2007-11-21 Bluetongue virus vaccine and immunogenic compositions, methods of use and methods of producing same
PCT/EP2008/065993 WO2009065930A1 (en) 2007-11-21 2008-11-21 Bluetongue virus vaccine and immunogenic compositions, methods of use and methods of producing same

Publications (1)

Publication Number Publication Date
ME01002B true ME01002B (me) 2012-10-20

Family

ID=39295947

Family Applications (1)

Application Number Title Priority Date Filing Date
MEP-2010-83A ME01002B (me) 2007-11-21 2008-11-21 Vakcina i imunogenične kompozicije za virus plavog jezika, postupci za njihovu upotrebu i postupci za njihovu izradu

Country Status (17)

Country Link
US (2) US9205145B2 (me)
EP (2) EP2062594A1 (me)
JP (1) JP2011504174A (me)
KR (3) KR20100096187A (me)
CN (1) CN101925363A (me)
AU (1) AU2008327827B2 (me)
BR (1) BRPI0820223B1 (me)
CA (1) CA2706514A1 (me)
CO (1) CO6280408A2 (me)
ES (1) ES2629992T3 (me)
ME (1) ME01002B (me)
MX (1) MX2010005622A (me)
PT (1) PT2222335T (me)
RU (1) RU2442603C2 (me)
UA (1) UA100710C2 (me)
WO (1) WO2009065930A1 (me)
ZA (1) ZA201004337B (me)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2062594A1 (en) * 2007-11-21 2009-05-27 Wyeth Farma, S.A. Bluetongue virus vaccine and immunogenic compositions, methods of use and methods of producing same
SG11201407619SA (en) * 2012-06-01 2014-12-30 Boehringer Ingelheim Vetmed Schmallenberg virus (sbv) vaccine, methods of production, and uses thereof
NZ703297A (en) * 2012-06-13 2016-04-29 Merial Ltd Reassortant btv and ahsv vaccines
CN103583813A (zh) * 2012-08-15 2014-02-19 邱世连 一种抗羊蓝舌病抗体饲料添加剂及制备方法
WO2014167582A2 (en) * 2013-03-31 2014-10-16 Ella Foundation Vaccine composition for prophylaxis in ruminants
AR107262A1 (es) * 2016-01-27 2018-04-11 Lilly Co Eli Inactivación de patógenos por delipidación
CN112390862B (zh) * 2020-10-27 2022-03-22 中国检验检疫科学研究院 用于检测蓝舌病的蛋白质及其编码基因和可溶制备方法
CN112870346A (zh) * 2021-01-21 2021-06-01 云南省畜牧兽医科学院 一种蓝舌病病毒二价灭活疫苗的制备方法

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE8205892D0 (sv) 1982-10-18 1982-10-18 Bror Morein Immunogent membranproteinkomplex, sett for framstellning och anvendning derav som immunstimulerande medel och sasom vaccin
US4545987A (en) * 1983-12-20 1985-10-08 Advanced Genetics Research Institute Psoralen inactivated double-stranded RNA viral vaccines
US5057540A (en) * 1987-05-29 1991-10-15 Cambridge Biotech Corporation Saponin adjuvant
CA1331443C (en) 1987-05-29 1994-08-16 Charlotte A. Kensil Saponin adjuvant
AUPM873294A0 (en) 1994-10-12 1994-11-03 Csl Limited Saponin preparations and use thereof in iscoms
BE1008978A5 (fr) * 1994-12-27 1996-10-01 Solvay Adjuvants pour vaccins.
UA56132C2 (uk) 1995-04-25 2003-05-15 Смітклайн Бічем Байолоджікалс С.А. Композиція вакцини (варіанти), спосіб стабілізації qs21 відносно гідролізу (варіанти), спосіб приготування композиції вакцини
GB9622159D0 (en) * 1996-10-24 1996-12-18 Solvay Sociutu Anonyme Polyanionic polymers as adjuvants for mucosal immunization
JP3464589B2 (ja) * 1997-06-05 2003-11-10 パナソニック コミュニケーションズ株式会社 中継機能付き通信装置及びその制御方法
WO1998056415A1 (en) * 1997-06-11 1998-12-17 Aquila Biopharmaceuticals, Inc. Purified saponins as oral adjuvants
ES2500490T3 (es) 1997-08-29 2014-09-30 Antigenics Inc. Composiciones que comprenden el adyuvante QS-21 y polisorbato o ciclodextrina como excipiente
EP2062594A1 (en) * 2007-11-21 2009-05-27 Wyeth Farma, S.A. Bluetongue virus vaccine and immunogenic compositions, methods of use and methods of producing same

Also Published As

Publication number Publication date
KR20130128450A (ko) 2013-11-26
RU2010120324A (ru) 2011-12-27
CA2706514A1 (en) 2009-05-28
CO6280408A2 (es) 2011-05-20
US9623106B2 (en) 2017-04-18
BRPI0820223B1 (pt) 2021-11-09
UA100710C2 (ru) 2013-01-25
AU2008327827B2 (en) 2014-05-01
AU2008327827A1 (en) 2009-05-28
EP2222335A1 (en) 2010-09-01
BRPI0820223A2 (pt) 2020-08-18
EP2222335B1 (en) 2017-05-10
JP2011504174A (ja) 2011-02-03
WO2009065930A1 (en) 2009-05-28
US20110027316A1 (en) 2011-02-03
MX2010005622A (es) 2010-11-12
KR20150029717A (ko) 2015-03-18
US20160058858A1 (en) 2016-03-03
KR20100096187A (ko) 2010-09-01
ZA201004337B (en) 2012-12-27
CN101925363A (zh) 2010-12-22
PT2222335T (pt) 2017-07-10
EP2062594A1 (en) 2009-05-27
RU2442603C2 (ru) 2012-02-20
ES2629992T3 (es) 2017-08-17
US9205145B2 (en) 2015-12-08

Similar Documents

Publication Publication Date Title
ME01002B (me) Vakcina i imunogenične kompozicije za virus plavog jezika, postupci za njihovu upotrebu i postupci za njihovu izradu
CR8638A (es) Vacuna agalactiae estreptococos
UA98812C2 (ru) Авирулентная активированная живая вакцина mycoplasma hyopneumoniae
MX2009006178A (es) Vacuna contra salmonela.
WO2014018596A3 (en) Alpha (1,2) fucosyltransferases suitable for use in the production of fucosylated oligosaccharides
MX2011010976A (es) Vacunas que comprenden cepas de mycoplasma bovis atenuadas y metodo para la atenuacion.
AR071917A1 (es) Vacunas contra la coccidiosis
WO2011094363A3 (en) Influenza virus compositions and methods for universal vaccines
WO2009058833A3 (en) Mycoplasma bovis vaccine
CL2016002402A1 (es) Composiciones inmunológicas que contiene histophilus somni atenuado
WO2012097185A3 (en) Omv vaccine against burkholderia infections
BRPI0821240B8 (pt) formas mutantes de estreptolisina o
CL2011000877A1 (es) Composicion inmunogena para el tratamiento y/o profilaxis de ganado contra infecciones microbiologicas porque comprende antigeno de mycoplasma bovis; metodo de coadministracion de dos o mas antigenos a un ganado bovino.
UA98506C2 (en) Attenuated mycoplasma gallisepticum strains
DK201300292A (en) Fish vaccine
BR112015005347A2 (pt) composto, composição farmacêutica, e, método para tratamento ou profilaxia de infecção por hiv ou para tratamento, profilaxia, ou atraso no início de aids
CO6361950A2 (es) Composiciones, vacunas y metodos del virus del herpes del ganado bovino -1
CY1116077T1 (el) Τοπικες συνθεσεις για την προληψη σεξουαλικα μεταδιδομενων ασθενειων και μεθοδοι για την παραγωγη αυτων
BR112015012274A2 (pt) vacina, uso de bactérias de pasteurella multocida vivas atenuadas, e, método para proteger um ruminante contra pneumonia causada por bactérias de pasteurella multocida
AR060182A1 (es) Polisacaridos capsulares tipo 5 y tipo 8 de cepas s. aureus de sobreproduccion
WO2014167582A3 (en) Vaccine composition for prophylaxis in ruminants
BR112013023354A2 (pt) vacina para rinite equina
WO2007135420A3 (en) Defective interfering virus
MX368601B (es) Composicion inmunogenica contra la aeromonas hydrophila.
WO2010085611A3 (en) Mycoplasma gallisepticum formulation